DekaBank Deutsche Girozentrale’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-8,900
| Closed | -$96K | – | 1441 |
|
|
2022
Q2 | $96K | Hold |
8,900
| – | – | ﹤0.01% | 1283 |
|
|
2022
Q1 | $101K | Buy |
8,900
+800
| +10% | +$10.5K | ﹤0.01% | 1272 |
|
|
2021
Q4 | $132K | Buy |
8,100
+200
| +3% | +$3.48K | ﹤0.01% | 1318 |
|
|
2021
Q3 | $134K | Hold |
7,900
| – | – | ﹤0.01% | 1265 |
|
|
2021
Q2 | $159K | Hold |
7,900
| – | – | ﹤0.01% | 1268 |
|
|
2021
Q1 | $117K | Hold |
7,900
| – | – | ﹤0.01% | 1270 |
|
|
2020
Q4 | $102K | Hold |
7,900
| – | – | ﹤0.01% | 1271 |
|
|
2020
Q3 | $73K | Buy |
+7,900
| New | +$84.4K | ﹤0.01% | 1151 |
|
|
2019
Q4 | – | Sell |
-8,600
| Closed | -$117K | – | 1229 |
|
|
2019
Q3 | $117K | Sell |
8,600
-8,600
| -50% | -$120K | ﹤0.01% | 901 |
|
|
2019
Q2 | $248K | Buy |
17,200
+6,600
| +62% | +$105K | ﹤0.01% | 997 |
|
|
2019
Q1 | $209K | Buy |
10,600
+2,000
| +23% | +$45.6K | ﹤0.01% | 1033 |
|
|
2018
Q4 | $220K | Sell |
8,600
-2,000
| -19% | -$47K | ﹤0.01% | 954 |
|
|
2018
Q3 | $209K | Sell |
10,600
-300
| -3% | -$6.13K | ﹤0.01% | 1055 |
|
|
2018
Q2 | $209K | Hold |
10,900
| – | – | ﹤0.01% | 1040 |
|
|
2018
Q1 | $181K | Sell |
10,900
-200
| -2% | -$3.35K | ﹤0.01% | 999 |
|
|
2017
Q4 | $181K | Hold |
11,100
| – | – | ﹤0.01% | 948 |
|
|
2017
Q3 | $181K | Hold |
11,100
| – | – | ﹤0.01% | 954 |
|
|
2017
Q2 | $184K | Hold |
11,100
| – | – | ﹤0.01% | 936 |
|
|
2017
Q1 | $157K | Sell |
11,100
-900
| -8% | -$12.8K | ﹤0.01% | 865 |
|
|
2016
Q4 | $193K | Buy |
+12,000
| New | +$193K | ﹤0.01% | 832 |
|
|
2016
Q2 | – | Sell |
-19,500
| Closed | -$157K | – | 1047 |
|
|
2016
Q1 | $157K | Sell |
19,500
-2,000
| -9% | -$16.4K | ﹤0.01% | 884 |
|
|
2015
Q4 | $208K | Buy |
21,500
+500
| +2% | +$4.99K | ﹤0.01% | 862 |
|
|
2015
Q3 | $237K | Buy |
21,000
+800
| +4% | +$9.79K | ﹤0.01% | 833 |
|
|
2015
Q2 | $256K | Buy |
20,200
+1,000
| +5% | +$10.8K | ﹤0.01% | 827 |
|
|
2015
Q1 | $179K | Sell |
19,200
-1,700
| -8% | -$19.2K | ﹤0.01% | 927 |
|
|
2014
Q4 | $303K | Buy |
20,900
+1,300
| +7% | +$15.4K | ﹤0.01% | 796 |
|
|
2014
Q3 | $203K | Buy |
19,600
+200
| +1% | +$2.62K | ﹤0.01% | 810 |
|
|
2014
Q2 | $314K | Hold |
19,400
| – | – | ﹤0.01% | 695 |
|
|
2014
Q1 | $315K | Buy |
19,400
+400
| +2% | +$5.69K | 0.01% | 657 |
|
|
2013
Q4 | $240K | Buy |
19,000
+500
| +3% | +$5.02K | ﹤0.01% | 640 |
|
|
2013
Q3 | $203K | Buy |
+18,500
| New | +$198K | ﹤0.01% | 660 |
|
Other funds holding VNDA
EIP
PAI
DekaBank Deutsche Girozentrale's VNDA Position: Q3 2022 in Review
DekaBank Deutsche Girozentrale sold out of Vanda Pharmaceuticals (VNDA) in Q3 2022, closing a stake of 8,900 shares — an estimated $96K sold.
DekaBank Deutsche Girozentrale first reported a position in VNDA in Q3 2013 and held it in 31 quarters. The position peaked at $315K in Q1 2014. 178 funds tracked by Wall St. Rank hold VNDA as of Q3 2022.
- DekaBank Deutsche Girozentrale reported no remaining Vanda Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
- DekaBank Deutsche Girozentrale sold 8,900 Vanda Pharmaceuticals shares in Q3 2022, an estimated $96K.
- DekaBank Deutsche Girozentrale first reported a position in Vanda Pharmaceuticals in Q3 2013 and held it in 31 quarters.
- DekaBank Deutsche Girozentrale's Vanda Pharmaceuticals position peaked at $315K in Q1 2014.
- 178 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2022.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2022, filed 2 Nov 2022.